Related Experiment Video

Updated: May 25, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer

K C Masoumi1, Gina Shaw-Hallgren, Ramin Massoumi

  • 1Molecular Tumor Pathology, Department of Laboratory Medicine, Lund University, Skåne University Hospital, 205 02 Malmö, Sweden.

Journal of Skin Cancer
|January 12, 2012
PubMed

Insights

The deubiquitination enzyme CYLD plays a crucial role in skin cancer. Its dysregulation, through repression or inactivation, impacts basal cell carcinoma and squamous cell carcinoma development by affecting key signaling pathways.

Area of Science:

  • Molecular Biology
  • Oncology
  • Dermatology

Background:

  • Ubiquitin and related proteins regulate cellular functions through post-translational modification.
  • Dysregulation of the ubiquitin system is implicated in various diseases, including skin cancer.
  • The deubiquitination enzyme CYLD is increasingly recognized for its role in non-melanoma skin cancers.

Purpose of the Study:

  • To review the current understanding of CYLD's involvement in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC).
  • To explore how CYLD regulates NF-κB and hedgehog signaling pathways in skin cancer development and progression.

Main Methods:

  • Literature review focusing on CYLD's function in non-melanoma skin cancers.
  • Analysis of CYLD's regulatory mechanisms in BCC and SCC.
  • Examination of CYLD's interaction with hedgehog and NF-κB signaling.

Main Results:

  • In BCC, CYLD is transcriptionally repressed by the hedgehog signaling pathway, and its downregulation promotes cancer progression via altered TrkC signaling.
  • In SCC, CYLD levels are unchanged, but catalytic inactivation is linked to tumor development.
  • CYLD's activity is critical for regulating NF-κB and hedgehog signaling in these skin cancers.

Conclusions:

  • CYLD is a key player in the pathogenesis of BCC and SCC, acting as a tumor suppressor.
  • Altered CYLD expression or activity, influenced by signaling pathways like hedgehog, contributes to non-melanoma skin cancer development.
  • Targeting CYLD or its regulatory pathways may offer therapeutic strategies for skin cancer.

More Related Videos

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma12:16

Patient Derived Cell Culture and Isolation of CD133+ Putative Cancer Stem Cells from Melanoma

Published on: March 13, 2013

Related Concept Videos

Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...